Back

Poosarla Sai Karthik

Tech guy with a busi... • 17h

Oversubscribed 103x – strong market trust ₹854 Cr from anchor investors – institutional backing Valuation at ~₹14,790 Cr – growth story priced in Turned profitable in Q1 FY25 – scalability in action High valuation – long-term play, not a quick flip It’s not just about getting new customers. What matters more is whether customers keep using the service and how much profit the company makes from each booking. Without repeat customers and good margins, growth can turn into a loss-making game.

Reply
2

More like this

Recommendations from Medial

Image Description

Mridul Das

Introvert! • 6m

This is mind blowing 🤯. The farmaceutical business is really the whale 🐋. ➡️ This Bangalore based Pharmacy-focused supply chain and marketplace platform Saveo has achieved remarkable growth, scaling 103X 🔥since its inception. ➡️In 2020 their reve

See More
2 Replies
2
32

Business karo India

Business karo India ... • 2m

Do you agree **Two types of startups dominate India today:** 1. **Profit-focused startups** – They grow steadily, solve real problems, and build sustainable models. 2. **Valuation-focused startups** – They chase funding, burn cash on discounts, an

See More
Reply
2

Vivek Joshi

Director & CEO @ Exc... • 2m

Our Latest Mandate As part of growth strategy of one of our clients they are actively exploring acquisition opportunities across the following areas: • Specialty Chemicals (EBITDA ≥ ₹25 Cr, export-ready, asset-backed) • Food Processing (EBITDA ≥ ₹10

See More
Reply
5
Image Description
Image Description

Havish Gupta

Figuring Out • 1y

Unique Startup Stories (12/20) Meet DeHaat, a $600 Million Agritech startup from Patna. About It • It was Founded by Amrendra Singh and Shashank Kumar in Patna, Bihar in 2012. • It provides quality agricultural resources, financial support, and a m

See More
10 Replies
2
9
Image Description
Image Description

Harsh Dwivedi

 • 

Medial • 1y

Top News of the Week: 1. Funding: - 25 Indian startups raised around $432 million in funding. These deals count 6 growth-stage deals and 16 early-stage deals while 3 early-stage startups kept their transaction details undisclosed. - On a weekly b

See More
2 Replies
5
35
Image Description
Image Description

Chirag

 • 

&OTHERS • 4m

Growth hides flaws. Crisis shows if you really have a business. That’s exactly what happened with Fittr. During COVID, Fittr became the poster child of India’s online fitness boom. Revenue soared from ₹58 Cr to ₹90 Cr. Investors rushed in. But beh

See More
2 Replies
21
Image Description
Image Description

Nimesh Pinnamaneni

 • 

Helixworks Technologies • 6m

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

See More
10 Replies
15
40

Thakur Ambuj Singh

Entrepreneur & Creat... • 1m

Antfin, an affiliate of Alibaba Group, is reportedly set to sell 18.8 Cr shares of foodtech major Eternal in a block deal worth around INR 5,375 Cr (about $613 Mn). This comes a day after the investor exited fintech major Paytm. Citing sources, CNBC

See More
Reply
9

Vivek Joshi

Director & CEO @ Exc... • 1m

Our Latest Mandate As part of growth strategy of one of our clients they are actively exploring acquisition opportunities across the following areas: • Specialty Chemicals (EBITDA ≥ ₹25 Cr, export-ready, asset-backed) • Food Processing (EBITDA ≥ ₹10

See More
Reply
1

Vivek Joshi

Director & CEO @ Exc... • 1m

Our Latest Mandate As part of growth strategy of one of our clients they are actively exploring acquisition opportunities across the following areas: • Specialty Chemicals (EBITDA ≥ ₹25 Cr, export-ready, asset-backed) • Food Processing (EBITDA ≥ ₹10

See More
Reply
3

Download the medial app to read full posts, comements and news.